Fairvalue-Calculator Fairvalue-Calculator
EN DE

GAGS (GAGS) Fair Value & Analysis

Consumer Defensive · AT · Market cap €35.8M

Price€15.10
Fair Value€24.64
Upside+63.2%
Quality95/100
Evidence: Medium Range €18.48 – €30.79

Fair value as of: Jun 25, 2026

Analysis

GAGS (GAGS) currently trades at €15.10, while our model-based Fair Value estimate is €24.64 — implying the stock looks roughly 63.2% undervalued today. We read business quality at 95/100 (high quality), in the Consumer Defensive sector. Bull case: trading below our estimate, it may offer upside if the fundamentals hold. Bear case: a low price can be a value trap when quality is weak or the data is thin (evidence: medium) — always confirm before acting.

About the company

Gurktaler Aktiengesellschaft produces and distributes herbal spirits in Austria. The company was founded in 1897 and is based in Vienna, Austria.

Open the full interactive analysis →

Similar stocks

Ambev S.A (ABEV) -60% Anheuser-Busch InBev SA (BUDFF) -28% 1NBA (1NBA) -14% Fomento Económico Mexicano, S.A. (FEMSAUBD) +108% Heineken N.V (HINKF) -14% Constellation Brands, Inc (STZ) +24%

Frequently asked questions

Is GAGS (GAGS) undervalued?
As of Jun 25, 2026, our model estimates a fair value of €24.64 versus a price of €15.10 — about +63% (undervalued). Model-based estimate, not financial advice.
What is the fair value of GAGS?
Our 21-model fair value for GAGS is €24.64 (as of Jun 25, 2026), built from audited fundamentals. The current price is €15.10.
What is the quality score of GAGS?
GAGS has a Quality Score of 95/100, measuring profitability, growth and balance-sheet strength from non-valuation factors.

How we calculate Fair Value

Each company is valued through a stack of independent intrinsic-value models (DCF variants, residual-income, multiples and more), blended into one family-balanced consensus and weighted by how much trustworthy data backs it. A separate quality layer scores the fundamentals. Every input is real reported data — nothing guessed.

Educational research only · not financial advice · no buy/sell recommendation. Model-based estimates are not certainties; their reliability depends on data quality and assumptions.